Page last updated: 2024-11-04

spiperone and Adenoma, Prolactin-Secreting, Pituitary

spiperone has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 3 studies

Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
spiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.

Research Excerpts

ExcerptRelevanceReference
"Eight patients with pituitary adenoma including four non-functioning adenomas, two growth hormone (GH) secreting adenomas, one ACTH secreting adenoma and one TSH secreting adenoma and ten normal healthy volunteers were examined."1.29[Clinical application of 11C-NMSP to the patients with pituitary adenoma other than prolactinoma]. ( Inoue, Y; Momose, T; Nishikawa, J; Sasaki, Y; Teramoto, A; Watanabe, T, 1993)
"In cultures of prolactinoma cells from patients normally responsive to bromocriptine therapy (n = 10), considered as controls, 10(-9) mol/L bromocriptine inhibited PRL release by 71 +/- 6% (+/- SE), and the half-inhibitory dose was 7 x 10(-11) mol/L."1.28Resistance to bromocriptine in prolactinomas. ( Bertrand, P; Delivet, S; Enjalbert, A; Gunz, G; Jaquet, P; Jedynak, CP; Kordon, C; Peillon, F; Pellegrini, I; Rasolonjanahary, R, 1989)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Momose, T1
Teramoto, A1
Nishikawa, J1
Inoue, Y1
Watanabe, T1
Sasaki, Y1
McChesney, R1
Sealfon, SC1
Tsutsumi, M1
Dong, KW1
Roberts, JL1
Bancroft, C1
Pellegrini, I1
Rasolonjanahary, R1
Gunz, G1
Bertrand, P1
Delivet, S1
Jedynak, CP1
Kordon, C1
Peillon, F1
Jaquet, P1
Enjalbert, A1

Other Studies

3 other studies available for spiperone and Adenoma, Prolactin-Secreting, Pituitary

ArticleYear
[Clinical application of 11C-NMSP to the patients with pituitary adenoma other than prolactinoma].
    Kaku igaku. The Japanese journal of nuclear medicine, 1993, Volume: 30, Issue:6

    Topics: Adenoma; Adult; Carbon Radioisotopes; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolac

1993
Either isoform of the dopamine D2 receptor can mediate dopaminergic repression of the rat prolactin promoter.
    Molecular and cellular endocrinology, 1991, Volume: 79, Issue:1-3

    Topics: Animals; Cell Line; Ergolines; Female; Hysterectomy; Ovariectomy; Pituitary Neoplasms; Plasmids; Pro

1991
Resistance to bromocriptine in prolactinomas.
    The Journal of clinical endocrinology and metabolism, 1989, Volume: 69, Issue:3

    Topics: 17-Hydroxycorticosteroids; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adolescent; Adult; Bromoc

1989